Most cited papers from Empros Pharma (Sweden)

The most cited paper from Empros Pharma (Sweden) is "Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity" (Ulf C. Holmbäck, Anders H. Forslund, Stefan Grudén et al., 2020), with 35 citations. Next come "Effects of a novel weight‐loss combination product containing orlistat and acarbose on obesity: A randomized, placebo‐controlled trial" (25) and "Treatment Patterns and Survival among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden - a Population-based Register-linkage and Medical Chart Review Study" (12).

Showing 8 of 8 papers. Every paper is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.